Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Beyond Pay-for-Performance: A free Webinar to help hospitals improve patient care

Attend the free Webinar, "Beyond Pay-for-Performance," and learn how today's national performance improvement efforts are helping hospitals improve patient care and reduce costs - and discover the tactics and strategies behind top-performing hospitals and health systems.

25 Jan 2010

Renowned heart specialists to discuss new cardiovascular treatment and patient care at public forum

World-leading cardiovascular specialists, researchers, family physicians and the public will learn what's new in cardiovascular treatment, patient care and research at the second annual Peter Munk Cardiovascular Symposium, Partnerships in Integrative Patient Care, on January 29 and 30 at the Toronto Metropolitan Hotel.

23 Jan 2010

Heart-healthy foods and activities for Valentine's Day

Heart disease is the leading cause of death for men and women nationwide so keep heart healthy foods, gifts and activities in mind this Valentine's Day.

23 Jan 2010

NJHA honors professionals and organizations for sustainable healthcare

Several individuals and organizations were honored at the 91st Annual Meeting of the New Jersey Hospital Association today at the Hyatt Regency Princeton.

23 Jan 2010

Pfizer reports final results from randomized Phase 3 trial of Sutent

Pfizer Inc. today announced final results from a randomized Phase 3 trial of Sutent (sunitinib malate) in patients with advanced pancreatic neuroendocrine tumors, a type of cancer which originates in the hormone-producing area of the pancreas.

23 Jan 2010

California Heart Center joins Cedars-Sinai Heart Institute and Cedars-Sinai Medical Care Foundation

The California Heart Center, the cardiology group that developed the nation's largest heart transplant program, has joined the Cedars-Sinai Heart Institute and Cedars-Sinai Medical Care Foundation.

22 Jan 2010

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular disease, today announced that the paper “An alpha-2C-Adrenergic Receptor Polymorphism Alters the Norepinephrine Lowering Effects and Therapeutic Response of the Beta Blocker Bucindolol in Chronic Heart Failure” was published in the January 2010 edition of the peer-reviewed journal Circulation: Heart Failure (http://circheartfailure.ahajournals.org).

22 Jan 2010

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

The federal Food and Drug Administration today approved a continuous-flow heart-assist device pioneered at the Texas Heart Institute (THI) at St. Luke’s Episcopal Hospital (SLEH) for use as a permanent treatment for advanced heart failure.

21 Jan 2010

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA.

21 Jan 2010

Vivian and Seymour Milstein Family Heart Center to open to patients in February

Ushering in a new era in comprehensive cardiac care, the Vivian and Seymour Milstein Family Heart Center celebrated its opening today at NewYork-Presbyterian Hospital/Columbia University Medical Center.

21 Jan 2010

FDA approves Thoratec's HeartMate II LVAS for DT

Thoratec Corporation, a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today that it has received FDA approval of its PMA (Pre-Market Approval) supplement, allowing the use of its HeartMate II LVAS (Left Ventricular Assist System) for Destination Therapy (DT).

21 Jan 2010

Study: Heart's ability to pump effectively is diminished among people with common lung disease

A new study from Columbia University Medical Center researchers, has found that the heart's ability to pump effectively is diminished among people with a common lung disease, even in people with no or mild symptoms.

21 Jan 2010

FDA approves HeartMate II for patients with severe heart failure

The U.S. Food and Drug Administration today approved the HeartMate II, a continuous-flow, left ventricular assist system as a support for severe heart failure patients who are not acceptable candidates for heart transplantation.

20 Jan 2010

Gambro acquires CHF Solutions

Gambro and CHF Solutions, Inc. (CHF) announced today that Gambro has acquired CHF, a medical device company that manufactures and distributes ultrafiltration devices to treat fluid overload.

20 Jan 2010

Erectile dysfunction can be strongly related to the development of CVD

In the first study of its kind, New England Research Institutes, Inc. (NERI) in collaboration with the Division of Cardiology, San Francisco General Hospital and the University of California, San Francisco tested whether erectile dysfunction (ED) can be used to reclassify patients according to their future risk of developing cardiovascular disease (CVD) beyond traditional risk factors (such as smoking, high blood pressure, high cholesterol, etc).

20 Jan 2010

WHO, CDC issue H1N1 updates

Though H1N1 (swine flu) activity worldwide has slowed, the potential of a new wave of infections in the northern hemisphere in late winter or early spring remains viable, Keiji Fukuda, the WHO's top flu expert, said Monday at the start of the WHO's weeklong executive board meeting, Reuters reports.

19 Jan 2010

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

St. Jude Medical, Inc. today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Genesis™ spinal cord stimulation system for the management of chronic pain.

18 Jan 2010

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

Journal of the American Medical Association: Funding of US Biomedical Research, 2003-2008 - After doubling in a decade, the rate of increase in biomedical research in the U.S. has slowed since 2005, and the level of funding from the National Institutes of Health and industry appears to have decreased by 2 percent in 2008, after adjusting for inflation, the authors of this study report.

18 Jan 2010

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Regulus Therapeutics Inc. today announced that new pre-clinical data from multiple therapeutic programs were presented at the “RNA Silencing: Mechanism, Biology and Application” Keystone Symposium held January 14 – 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.

18 Jan 2010

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Elevated levels of DNA damage have for the first time been found in the cellular mitochondria and nuclei of patients with the inherited, progressive nervous system disease called Friedreich's ataxia (FRDA), says a multicenter research team led by an expert from the University of Pittsburgh Cancer Institute (UPCI).

18 Jan 2010

Heart Failure News and Research

Further Reading

Beyond Pay-for-Performance: A free Webinar to help hospitals improve patient care

Renowned heart specialists to discuss new cardiovascular treatment and patient care at public forum

Heart-healthy foods and activities for Valentine's Day

NJHA honors professionals and organizations for sustainable healthcare

Pfizer reports final results from randomized Phase 3 trial of Sutent

California Heart Center joins Cedars-Sinai Heart Institute and Cedars-Sinai Medical Care Foundation

Norepinephrine responses to bucindolol influenced by alpha-2C adrenergic receptor genotype

FDA approves continuous-flow heart-assist device pioneered at Texas Heart Institute at SLEH

China Pharma Holdings announces completion of clinical trials for Candesartan

Vivian and Seymour Milstein Family Heart Center to open to patients in February

FDA approves Thoratec's HeartMate II LVAS for DT

Study: Heart's ability to pump effectively is diminished among people with common lung disease

FDA approves HeartMate II for patients with severe heart failure

Gambro acquires CHF Solutions

Erectile dysfunction can be strongly related to the development of CVD

WHO, CDC issue H1N1 updates

Japanese MHLW approves St. Jude Medical's Genesis spinal cord stimulation system

Health Policy Research Roundup: New Orleans clinic experiences, health reform and lagging biomedical research funds

Regulus Therapeutics presents new data on oncology, immune disease and HCV therapeutic programs

Findings could pave way for new therapeutic approaches for Friedreich's ataxia

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News